当前位置:APASL-en-亚太肝脏研究协会年会 >> 正文
[APASL2014]New Development of DAA Therapies——Interview with Dr.Michael Beard
—— 作者:M.Beard 时间:2014-03-12
阅读数:
124
简介:The previous treatments up to around 2011 were interferon and ribavirin and they were two drugs that actually targeted the host cell and created an environment that was unfavorable for virus replication through either modulating the immune system or turning on a lot of genes in the cell that were antiviral.
请登录后查看详细内容
标签:
专家访谈
专家访谈
其他肝病
发表评论
全部评论